Bacteroides Fragilis ‐Derived Ceramide‐1‐phosphate Contributes to Depression Comorbidity in Irritable Bowel Syndrome Through Hippocampal SMPD4 and Myelin Disruption
Year: 2026
Type: article
Abstract: Depression affects more than one-third of patients with diarrhea-predominant irritable bowel syndrome (IBS-D), yet the gut-brain mechanisms remain poorly understood. Here, we identified enrichment of Bacteroides fragilis in IBS-D patients with comorbid depression, with relative abundance positively correlating with Hamilton Depression Rating Scale scores. B. fragilis exposure induced depressive-like behaviors in antibiotic-treated and germ-free mice and was accompanied by reduced hippocampal sphingomyelin phosphodiesterase 4 (SMPD4), altered myelin-associated gene programs, and myelin loss. A combined hippocampal rescue strategy using Syn- and MBP-promoter AAV vectors restored SMPD4 expression and improved behavioral and myelin-related outcomes. B. fragilis cultures and a C1P-producing engineered bacterial strain supported an association between bacterial sphingolipid production and the phenotype, whereas peripheral C1P administration increased hippocampal C1P and reduced SMPD4 and myelin markers. Dietary branched-chain amino acid restriction reduced systemic C1P-associated signals, restored SMPD4 expression, and partially improved depressive-like phenotypes. Collectively, the findings support a B. fragilis-associated C1P-SMPD4 pathway linking intestinal dysbiosis to hippocampal sphingolipid imbalance and myelin disruption, while leaving the route and molecular form by which peripheral lipid signals influence the brain unresolved.
Source: Advanced Science
DOI: 10.1002/advs.78678
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,730
OpenAlex ID: W7233730164
